For the Inventor, By the Inventor

Enter assignee name

Taro Pharmaceutical Industries Limited

USPTO Granted Patents = 38

EPO Patents = 5

Trademarks = 5

Forward Citations = 304

Loading Chart...

Loading Chart...

60 inventors (with patents filed for the assignee):

Daniella Gutman (7 out of 23 patents)

Avi Avramoff (6 out of 14 patents)

Daniel A Moros (6 out of 28 patents)

4. Ron Schlinger (5 out of 11 patents)

5. Helena Shifrin (5 out of 12 patents)

6. Tzviel Sheskin (5 out of 6 patents)

7. Avraham Yacobi (5 out of 17 patents)

8. Barrie Levitt (5 out of 10 patents)

9. Rosa L Cyjon (5 out of 17 patents)

10. Vered Rosenberger (4 out of 5 patents)

11. Irena Oleinik (4 out of 4 patents)

12. Sorin Bercovici (4 out of 4 patents)

13. Dan Moros (4 out of 5 patents)

14. Daniela Gutman (3 out of 4 patents)

15. Hershel Herzog (3 out of 4 patents)

38 patents: Sort by Forward Citations

1. 12233055 - Topical Montelukast formulations (2025-02-25),

2. 11844861 - Topical Montelukast formulations (2023-12-19),

3. 11691946 - Preparation of Trifarotene and intermediates and polymorphs thereof (2023-07-04),

4. 11559541 - Topical capecitabine for the treatment of hyperproliferative skin conditions (2023-01-24),

5. 11173117 - Topical Montelukast formulations (2021-11-16),

6. 10548837 - Topical montelukast for treatment of atopic dermatitis (2020-02-04),

7. 10112970 - Process for the preparation of 17-desoxy-corticosteroids (2018-10-30),

8. 9334219 - Process for the preparation of a stable polymorphic form of Atovaquone (2016-05-10),

9. 9233898 - Process for the preparation of 2-phenyl-1,3-propanediol (2016-01-12),

10. 8314115 - Method of treating movement disorders using barbituric acid derivatives (2012-11-20),

11. 8158639 - Non-sedating barbiturate compounds as neuroprotective agents (2012-04-17),

12. 7776871 - Method of treating movement disorders using barbituric acid derivatives (2010-08-17),

13. 7723346 - Non-sedating barbiturate compounds as neuroprotective agents (2010-05-25),

14. 7696356 - Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom (2010-04-13),

15. 7683162 - Process of preparing a crystalline azithromycin monohydrate (2010-03-23),

Taro Pharmaceutical Industries Limited is a multinational pharmaceutical company specializing in generic medications. Headquartered in Haifa, Israel, Taro operates globally with a focus on the United States market. With a wide range of pharmaceutical products, Taro aims to improve patients' lives by offering cost-effective and high-quality medications. Visit their website for more information and product details.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

38 Patents

#9 in Haifa

#128 in Israel

#17,275 in the World

Taro Pharmaceutical Industries Limited

Forward Citations = 304

60 inventors:

Daniella Gutman (7 out of 23 patents)

Avi Avramoff (6 out of 14 patents)

Daniel A Moros (6 out of 28 patents)

4. Ron Schlinger (5 out of 11 patents)

5. Helena Shifrin (5 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…